International centers of science publicly clamored over an announcement made by Endo Pharmaceuticals after the American drug giant told the world of a pioneering gel of their creation that was designed to prevent the spread of HIV/AIDS through normal application and use.
On a world stage looking for any form of scientific breakthrough to battle the often fatal juggernaut that is AIDS, any glimmer of hope is just as good as the next; in this case, the next would do best to come sooner than later because the gel is nothing more than a over-hyped bust.
Clinical trials of over 9,000 women found sounded the proverbial death knoll for the vaginal microbicide, with none of the subjects exhibiting any resistance to any AIDS/HIV viral strain.
Nearly 33.4 million people were recorded as having HIV in 2008; that same year saw 2 million people of AIDS complications.
